There May Be Some Bright Spots In Shanghai Hile Bio-Technology's (SHSE:603718) Earnings

Shareholders appeared unconcerned with Shanghai Hile Bio-Technology Co., Ltd.'s (SHSE:603718) lackluster earnings report last week. We think that the softer headline numbers might be getting counterbalanced by some positive underlying factors.

View our latest analysis for Shanghai Hile Bio-Technology

The Impact Of Unusual Items On Profit

To properly understand Shanghai Hile Bio-Technology's profit results, we need to consider the CN¥19m expense attributed to unusual items. While deductions due to unusual items are disappointing in the first instance, there is a silver lining. We looked at thousands of listed companies and found that unusual items are very often one-off in nature. And, after all, that's exactly what the accounting terminology implies. Shanghai Hile Bio-Technology took a rather significant hit from unusual items in the year to March 2024. As a result, we can surmise that the unusual items made its statutory profit significantly weaker than it would otherwise be.

Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Shanghai Hile Bio-Technology.

Our Take On Shanghai Hile Bio-Technology's Profit Performance

As we discussed above, we think the significant unusual expense will make Shanghai Hile Bio-Technology's statutory profit lower than it would otherwise have been. Because of this, we think Shanghai Hile Bio-Technology's underlying earnings potential is as good as, or possibly even better, than the statutory profit makes it seem! And on top of that, its earnings per share have grown at an extremely impressive rate over the last three years. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. So while earnings quality is important, it's equally important to consider the risks facing Shanghai Hile Bio-Technology at this point in time. Every company has risks, and we've spotted 4 warning signs for Shanghai Hile Bio-Technology you should know about.

This note has only looked at a single factor that sheds light on the nature of Shanghai Hile Bio-Technology's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying to be useful.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.